Anakinra
Anakinra is a pharmaceutical drug with 116 clinical trials. Currently 19 active trials ongoing. Historical success rate of 82.7%.
Success Metrics
Based on 67 completed trials
Phase Distribution
Phase Distribution
32
Early Stage
52
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.1%
67 of 88 finished
23.9%
21 ended early
19
trials recruiting
116
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Randomised Evaluation of COVID-19 Therapy
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Giant Cell Arteritis and Anakinra Trial
Clinical Trials (116)
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Randomised Evaluation of COVID-19 Therapy
A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
Giant Cell Arteritis and Anakinra Trial
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes
Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
Anakinra in Dengue With Hyperinflammation ( AnaDen )
Dupilumab_Metastatic NSCLC
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
MIS-C Comparative Effectiveness Study
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 116